Recent Finacing
Recent Raise
Mutabilis develops therapeutic agents targeting antibiotic‑resistant "nightmare" bacteria to treat infections caused by multi‑drug‑resistant pathogens.
Focus Areas
Funding round
See the team members at Mutabilis.
